Musk’s takeover of US health agencies raises pandemic threat, experts warn Doge wreaks havoc on HHS and CDC as Trump seeks to grant committee sweeping governmental powers The Guardian - US · Feb 15, 2025
‘It’s a money game to them’: a son takes on UnitedHealth over his elderly father’s care Robby Martin has joined a lawsuit against UnitedHealth after the insurance giant cut off his father’s nursing home coverage – five days later his father died at home The Guardian - US · Feb 13, 2025
Government remains behind ECB’s decision to fulfil Afghanistan fixture Secretary of State for Culture, Media and Sport, Lisa Nandy, feels a boycott would be “counterproductive”. The Independent UK · Feb 11, 2025
What You Need to Know About Elon Musk's DOGE's Access to Medicare Systems Officials at Musk-led DOGE were given access to agency data systems and technology at the Centers for Medicare and Medicaid Services (CMS), an agency with a $2 trillion budget. Kiplinger · Feb 6, 2025
Elon Musk's DOGE Targets Potential Fraud In Medicare And Medicaid DOGE collaborates with CMS to investigate potential fraud in Medicare and Medicaid systems, aiming to combat improper payments and enhance efficiency. Top News · Feb 5, 2025
Call Center Workers Continue Union Push After Biden Administration Drops Fight Officials withdrew a rebid of a $6.6 billion contract requiring “labor harmony” 25 days after the $5 billion corporation holding it filed suit. Capital & Main · Jan 22, 2025
Trump Revokes Biden's Order to Lower Drug Prices for Medicare President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare enrollees. Kiplinger · Jan 21, 2025
Medicare Price Negotiations To Continue Under the Trump Administration The Centers for Medicare & Medicaid Services plans to negotiate the prices for 15 new drugs, although it says its seeking "greater transparency" in price talks. Kiplinger · Jan 17, 2025
What to Expect From CMS Energy's Q4 2024 Earnings Report CMS Energy is slated to release its fourth-quarter results next month, and analysts forecast double-digit drop in its bottom-line figure. Barchart · Jan 15, 2025
Alzheimer’s may not be from amyloids Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease Salon · Jan 11, 2025
Is CMS Energy Stock Underperforming the Nasdaq? CMS Energy has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects. Barchart · Dec 24, 2024
The pros and cons of Medicare Advantage plans Advice to help you choose between Original Medicare and Medicare Advantage plans. Fortune · Dec 17, 2024
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth These three high-tech micro-cap stocks have made solid business progress in 2024, warranting them to be on investors radars in 2025. MarketBeat · Dec 17, 2024
Over 162,000 Dreamers Cut Off From Affordable Care Act Insurance A federal court in North Dakota has blocked ACA coverage for DACA recipients in 19 states. Here's what it means. Kiplinger · Dec 11, 2024
Fortune · Dec 6, 2024 Dr. Oz turbocharges Medicare Advantage and everyone monitors their glucose: 10 health care predictions for 2025 from top investors Although Trump is entering the White House with an electoral mandate, he will not spend any political capital on health care legislation.
Kiplinger · Dec 5, 2024 2025 Open Enrollment: DACA Recipients Can Purchase Affordable Care Act Health Insurance Over 100,000 people are newly eligible to purchase health insurance from the federal marketplace. Here's what you need to know.
Roll Call · Dec 5, 2024 How backlash to the pandemic helped shape Trump’s health picks - Roll Call Cabinet health picks include vaccine skeptics, supporters of herd immunity and promoters of hydroxychloroquine to treat COVID-19.
Benzinga · Dec 2, 2024 Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics warn it may hinder patient access and innovation.
Salon · Nov 30, 2024 Dr. Oz's finanical conflicts of interest Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000
The Guardian - UK · Nov 29, 2024 Here’s one way to slash Britain’s rate of child poverty: stop dithering and make all fathers pay what’s due A new report shows a bad situation is getting worse. This really is a case for draconian action from the state, says Guardian columnist Polly Toynbee
Benzinga · Nov 27, 2024 Maximus Secures Medicare Contract Through 2031, Shares Gain Momentum Maximus announces CMS has canceled the early re-procurement of its Medicare contract, allowing the company to continue its current work until 2031.
The Independent UK · Nov 26, 2024 Cheap Ozempic? Millions of obese Americans wait on Trump’s decision Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
Roll Call · Nov 26, 2024 White House rule would expand coverage of anti-obesity drugs - Roll Call It’s unclear whether incoming President Donald J. Trump will support outgoing President Joe Biden’s plan to insure the weight loss drugs.
Kiplinger · Nov 21, 2024 Trump Picks Dr. Oz as Head of Medicare and Medicaid President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
Barchart · Nov 21, 2024 What Are Wall Street Analysts' Target Price for CMS Energy Stock? CMS Energy has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.